SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKIGlobeNewsWire · 3 days ago
FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic ConditionGlobeNewsWire · Oct 7, 2026
Roche launches newborn screening test for three severe genetic conditionsGuruFocus · Sep 30, 2026
SCD: High Midstream/Low Bond Exposure Is A Good CombinationSeeking Alpha · Sep 2, 2026
10 Best CEFs This Month: Average Yield Of Near 10% (August 2026)Seeking Alpha · Aug 29, 2026
Galmed Announces Breakthrough Development of Dispersible Film Delivery (ODF), Brain Penetrating formulation of its SCD1 inhibitor Aramchol for Parkinson's Disease, Targeting $6 Billion MarketPRNewsWire · Jul 28, 2026The LMP Capital and Income Fund Inc. operates as a closed-end balanced mutual fund, primarily overseen by Legg Mason Partners Fund Advisor, LLC. Additional management responsibilities are shared with Clearbridge Investments, LLC, Western Asset Management Company Limited, and Western Asset Management Company. Its investment mandate extends globally, encompassing both public equity and fixed-income securities from businesses spanning various sectors.